Dermatology Search
Dermatology Dermatology
scleroderma
SCLERODERMA
Scleroderma is a connective tissue disorder characterized by skin thickening and fibrosis. It is rare, autoimmune and chronic.
It has an idiopathic cause and not contagious.
Early microvascular damage, mononuclear cell infiltrates and slowly developing fibrosis are the important features of the tissue lesions.
The leading causes of death are pulmonary fibrosis and pulmonary arterial hypertension.
Drug Information

Indication: Erectile dysfunction.

Indication: Erectile dysfunction.

Indication: CHD: Chronic stable angina pectoris; HTN.

Indication: Erectile dysfunction.

Indication: Acute & chronic rheumatic fever, RA, bronchial asthma, myositis, dermatitis.

Bufencon
betamethasone dipropionate + betamethasone disodiu...

Indication: Rheumatic disorders, collagen disease, allergic states.

Diprospan
betamethasone dipropionate + betamethasone disodiu...

Indication: Adjunctive treatment of acute & chronic corticosteroid-responsive disorders.

Indication: Erectile dysfunction.

Indication: Erectile dysfunction.

Indication: Class II & III pulmonary arterial HTN in adult patients. Primary pulmonary & pulmonary HTN associated ...

1  /  3
1  /  3
Editor's Recommendations
Most Read Articles
Clindamycin shows promise as alternative treatment to antibiotics in hidradenitis suppurativa
25 Apr 2019
A recent study has demonstrated the potential of clindamycin as a treatment alternative to antibiotic combination regardless of hidradenitis suppurativa (HS) clinical stage.
Healthy diet prevents wrinkling in women
28 Apr 2019
Women who adopt healthy diets appear to have less severe facial wrinkles, according to a new Dutch study.
Original New Drug Application Approvals by US FDA (16 - 30 April 2019)
01 May 2019
New drug applications approved by US FDA as of 16 - 30 April 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.